Literature DB >> 23135769

[Successful use of C1 esterase inhibitor in capillary leak syndrome].

R Seidel1.   

Abstract

This article reports the successful use of C1 esterase inhibitor in the treatment of capillary leak syndrome. The coincidence of exposure to latex during surgery and medication with ramipril led to prolonged shock complicated by secondary hyperfibrinolysis, capillary leak syndrome and multiple organ failure. Initial treatment according to relevant guidelines failed to stabilize the condition. Treatment was only successful after administration of 1,500 IU of human C1 esterase inhibitor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135769     DOI: 10.1007/s00101-012-2092-3

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  12 in total

1.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Authors:  Marco Cicardi; Aleena Banerji; Francisco Bracho; Alejandro Malbrán; Bernd Rosenkranz; Marc Riedl; Konrad Bork; William Lumry; Werner Aberer; Henning Bier; Murat Bas; Jens Greve; Thomas K Hoffmann; Henriette Farkas; Avner Reshef; Bruce Ritchie; William Yang; Jürgen Grabbe; Shmuel Kivity; Wolfhart Kreuz; Robyn J Levy; Thomas Luger; Krystyna Obtulowicz; Peter Schmid-Grendelmeier; Christian Bull; Brigita Sitkauskiene; William B Smith; Elias Toubi; Sonja Werner; Suresh Anné; Janne Björkander; Laurence Bouillet; Enrico Cillari; David Hurewitz; Kraig W Jacobson; Constance H Katelaris; Marcus Maurer; Hans Merk; Jonathan A Bernstein; Conleth Feighery; Bernard Floccard; Gerald Gleich; Jacques Hébert; Martin Kaatz; Paul Keith; Charles H Kirkpatrick; David Langton; Ludovic Martin; Christiane Pichler; David Resnick; Duane Wombolt; Diego S Fernández Romero; Andrea Zanichelli; Francesco Arcoleo; Jochen Knolle; Irina Kravec; Liying Dong; Jens Zimmermann; Kimberly Rosen; Wing-Tze Fan
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

Review 2.  An overview of novel therapies for acute hereditary angioedema.

Authors:  Rafael Firszt; Michael M Frank
Journal:  Am J Clin Dermatol       Date:  2010-12-01       Impact factor: 7.403

3.  C1-esterase inhibitor infusion increases survival rates for patients with sepsis*.

Authors:  Anton A Igonin; Denis N Protsenko; Gennadiy M Galstyan; Alexey V Vlasenko; Nana N Khachatryan; Igor V Nekhaev; Sergey A Shlyapnikov; Natalya B Lazareva; Paul Herscu
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

Review 4.  Hereditary angioedema: an update on available therapeutic options.

Authors:  Marcus Maurer; Markus Magerl
Journal:  J Dtsch Dermatol Ges       Date:  2010-06-29       Impact factor: 5.584

Review 5.  Angioedema due to C1 inhibitor deficiency in 2010.

Authors:  Marco Cicardi; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2010-05-22       Impact factor: 3.397

Review 6.  C1 inhibitor, a multi-functional serine protease inhibitor.

Authors:  Alvin E Davis; Fengxin Lu; Pedro Mejia
Journal:  Thromb Haemost       Date:  2010-08-30       Impact factor: 5.249

Review 7.  Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC).

Authors:  Craig S Kitchens
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

8.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Authors:  Timothy J Craig; Robyn J Levy; Richard L Wasserman; Againdra K Bewtra; David Hurewitz; Krystyna Obtułowicz; Avner Reshef; Bruce Ritchie; Dumitru Moldovan; Todor Shirov; Vesna Grivcheva-Panovska; Peter C Kiessling; Heinz-Otto Keinecke; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol       Date:  2009-09-19       Impact factor: 10.793

9.  Ecallantide for the treatment of hereditary angiodema in adults.

Authors:  Michael Lunn; Erin Banta
Journal:  Clin Med Insights Cardiol       Date:  2011-05-17

Review 10.  Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.

Authors:  Mervyn Singer; Annie M Jones
Journal:  Crit Care       Date:  2011-01-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.